Skip to main content
Journal cover image

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

Publication ,  Journal Article
AASLD-IDSA HCV Guidance Panel,
Published in: Clin Infect Dis
October 30, 2018

Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-based process for the expeditious formulation and dissemination of evidence-based recommendations. Launched in 2014, the hepatitis C virus (HCV) guidance website undergoes periodic updates as necessitated by availability of new therapeutic agents and/or research data. A major update was released electronically in September 2017, prompted primarily by approval of new direct-acting antiviral agents and expansion of the guidance's scope. This update summarizes the latest release of the HCV guidance and focuses on new or amended recommendations since the previous September 2015 print publication. The recommendations herein were developed by volunteer hepatology and infectious disease experts representing AASLD and IDSA and have been peer reviewed and approved by each society's governing board.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

October 30, 2018

Volume

67

Issue

10

Start / End Page

1477 / 1492

Location

United States

Related Subject Headings

  • United States
  • Renal Insufficiency, Chronic
  • Practice Guidelines as Topic
  • Microbiology
  • Humans
  • Hepatitis C, Chronic
  • Hepatitis C
  • Hepacivirus
  • Antiviral Agents
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
AASLD-IDSA HCV Guidance Panel, . (2018). Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis, 67(10), 1477–1492. https://doi.org/10.1093/cid/ciy585
AASLD-IDSA HCV Guidance Panel, Georgia M. “Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.Clin Infect Dis 67, no. 10 (October 30, 2018): 1477–92. https://doi.org/10.1093/cid/ciy585.
AASLD-IDSA HCV Guidance Panel, Georgia M. “Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.Clin Infect Dis, vol. 67, no. 10, Oct. 2018, pp. 1477–92. Pubmed, doi:10.1093/cid/ciy585.
Journal cover image

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

October 30, 2018

Volume

67

Issue

10

Start / End Page

1477 / 1492

Location

United States

Related Subject Headings

  • United States
  • Renal Insufficiency, Chronic
  • Practice Guidelines as Topic
  • Microbiology
  • Humans
  • Hepatitis C, Chronic
  • Hepatitis C
  • Hepacivirus
  • Antiviral Agents
  • 3202 Clinical sciences